Researchers at the University of Oregon have reconstructed antimicrobial peptides from 160 million years ago, discovering that ancient fragments can outperform modern human versions against drug-resistant bacteria. Published August 25 in PLOS Biology, the study explores how mammalian immune defenses evolved to combat microbial threats, offering potential blueprints for future infection treatments.
University of Oregon Researchers Reconstruct Extinct Lactoferrin
Scientists investigated lactoferrin, an immune protein present in tears, saliva, intestinal mucus, and breast milk, as reported by the source articles. The protein starves bacteria of iron and uses an embedded antimicrobial peptide to attack microbial membranes. The source articles note that lactoferrin emerged following a gene duplication event in the ancestor of placental mammals approximately 160 million years ago.
The research team utilized genetic sequences from living animals, including humans and cows, to map evolutionary relationships. Using ancestral sequence reconstruction, researchers predicted ancient gene sequences, synthesized them in the laboratory, and produced reconstructed proteins for testing against human disease-associated bacteria.
Ancient Antimicrobial Peptides Tested Against Modern Drug-Resistant Pathogens
The synthesized peptides were tested against Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, and Streptococcus. The source articles note that transferrin-derived peptides showed little antimicrobial activity, whereas the earliest reconstructed lactoferricin, AncLFcin1, reduced bacterial growth by more than 50% at higher concentrations, such as 400 micrograms per milliliter for P. aeruginosa.
As researchers moved forward through evolutionary time, potency increased. AncLFcin2 showed high potency at 100 micrograms per milliliter against P. aeruginosa and 50 micrograms per milliliter against E. coli and an S. aureus strain. Modern bovine lactoferricin restricted bacterial growth at concentrations as low as 50 micrograms per milliliter, while human lactoferricin performed better against Gram-negative bacteria than Gram-positive bacteria.
Single Amino Acid Mutations Drive Immune Defense Potency
The study identified that single amino acid mutations substantially enhanced peptide activity. Researchers observed an accumulation of positively charged and hydrophobic amino acids over evolutionary time, which improved interactions with bacterial cell envelopes. The source articles note that a single arginine substitution contributed to the early emergence of lactoferricin antimicrobial activity, specifically strengthening activity against Pseudomonas aeruginosa.
Did you know?
Lactoferrin is found in almost every bodily fluid except blood, serving a dual role by binding iron to starve bacteria and deploying short peptides to pierce microbial cell membranes.
Limitations and Blueprints for Future Infection Treatments
The ancient peptides are not ready-made drugs. Antimicrobial peptides can lack the structural stability of conventional drugs and degrade quickly inside the human body, according to the source articles. Instead, the evolutionary data provides structural blueprints for developing new treatments that work alongside existing antibiotics and helps scientists predict how pathogens might develop resistance.
Frequently Asked Questions About Ancient Mammalian Immune Proteins
What is lactoferricin and where is it located?
Lactoferricin is a 25-amino-acid antimicrobial region embedded within the larger lactoferrin protein, corresponding to positions 17 through 42 of mature human lactoferrin. It contains positively charged and hydrophobic amino acids that target bacterial cell envelopes.
Which bacterial strains were tested in the PLOS Biology study?
The research team tested the reconstructed peptides against Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, and Streptococcus agalactiae.
How do ancient peptides compare in strength to modern versions?
Older reconstructed peptides damaged bacterial membranes, but microbes could often repair themselves. Peptides originating from relatively recent mammalian ancestors grew progressively more potent, outperforming modern human peptides against certain drug-resistant bacteria.
Keep reading